戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 randomized between open and MI esophagectomy with curative intent.
2 not resectable, and recurrent but resectable with curative intent.
3                    Hence, many are treatable with curative intent.
4 y-seven percent of patients were operated on with curative intent.
5 tastases, cervical operation was carried out with curative intent.
6  are amenable to a second surgical procedure with curative intent.
7 hed a role for this operation when performed with curative intent.
8 t operation and 33 (77%) underwent resection with curative intent.
9 are at high risk of recurrence after surgery with curative intent.
10 vival was performed for all patients treated with curative intent.
11 ity after the treatment of colorectal cancer with curative intent.
12 concurrent chemoradiotherapy or radiotherapy with curative intent.
13 y, newly diagnosed HIV-cHL should be managed with curative intent.
14 t-line therapy of carboplatin and paclitaxel with curative intent.
15 nt esophageal cancer after initial treatment with curative intent.
16  recurrent esophageal cancer after treatment with curative intent.
17 F-FDG PET or PET/CT after previous treatment with curative intent.
18 h liver metastases undergo hepatic resection with curative intent.
19 , and survival after treatment of recurrence with curative intent.
20 creatic cancer is poor, even after resection with curative intent.
21 diotherapy, bioradiotherapy, or radiotherapy with curative intent.
22 ely identified patients operated on for LMCO with curative intent.
23 studies compared AS with immediate treatment with curative intent.
24  reported comparisons of WW versus treatment with curative intent.
25 osis patients with single, small HCC treated with curative intent.
26 dic surveillance ultrasound who were treated with curative intent.
27 duals, with 35 new localized cancers treated with curative intent.
28  adenocarcinoma who underwent pancreatectomy with curative intent.
29 t of 104 HNSCC patients undergoing treatment with curative intent.
30 stly for palliation, but have also been used with curative intent.
31  nonsurgical local therapy to the liver mass with curative intent.
32 ollicular lymphoma grade 3 should be treated with curative intent.
33 atic resection for pancreatic adenocarcinoma with curative intent.
34 nal gastrinoma and regional nodal metastases with curative intent.
35 ents after colorectal cancer (CRC) resection with curative intent.
36 th gastric cancer undergo surgical resection with curative intent.
37  disease; 160 patients underwent exploration with curative intent.
38 ve surgery plus intraperitoneal chemotherapy with curative intent.
39 arenchyma who underwent lung transplantation with curative intent.
40 7 participants with incident HPV-OPC treated with curative intent, 124 had 1 or more posttreatment or
41     Of 801 patients with primary LS resected with curative intent, 369 (46%) presented with well-diff
42 polychemotherapy and/or salvage-radiotherapy with curative intent (42%), and palliative approaches (3
43 tic cancer and enter an era in which surgery with curative intent actually fulfills this goal on a mu
44                         Expectant management with curative intent aims to follow patients with early
45 ients with comorbidities can undergo therapy with curative intent and achieve successful long-term ou
46  have a reasonable fitness level are treated with curative intent and offered induction chemotherapy.
47 atic cancer who were no longer being treated with curative intent (and 87 caregivers) were randomly a
48 reast cancer and patients with NSCLC treated with curative intent, and decreased with age for patient
49  carefully selected men, active surveillance with curative intent appears to be a safe alternative to
50 nical problem, and radical treatment options with curative intent are not generally accepted.
51 dered for surgery or definitive radiotherapy with curative intent before PET/CT was entered into a pr
52 ients who underwent liver resection for MCRC with curative intent between 1991 and 2002 were reviewed
53 val in patients undergoing surgery for NSCLC with curative intent, but many of these claims are uncon
54  Of 63 patients with prostate cancer treated with curative intent by a single radiation oncologist be
55 genes in patients with stage I NSCLC treated with curative intent by means of surgery is associated w
56                         Locoregional therapy with curative intent (CLRT) followed by salvage liver tr
57 sed rate of surgical treatment of recurrence with curative intent compared with minimal follow-up; th
58                    Of these, 15 were treated with curative intent due to the presence of locoregional
59 tage tumors were more likely to be treatable with curative intent (Dukes' A: 13/26, 50%; Dukes' B: 32
60 up comprised 2,976 patients who were treated with curative intent either by laparoscopic gastrectomy
61 eristics of patients who underwent resection with curative intent for ductal adenocarcinoma of the pa
62 lood or marrow transplantation (BMT) is used with curative intent for hematologic malignancies.
63           Thirty percent of patients treated with curative intent for localized prostate cancer (PC)
64 nts, treated with radical prostatectomy (RP) with curative intent for PCa who showed rising PSA level
65 median age 62 years) who underwent resection with curative intent for small HCC was identified from a
66 operative PET/CT scan and surgical resection with curative intent from 2001 to 2009 were identified f
67 nts undergoing multimodal therapy or surgery with curative intent from 2006 to mid-2013 were studied.
68      Of 521 patients who underwent treatment with curative intent from July 1, 2002, to June 30, 2006
69 nderwent surgical resection of their disease with curative intent (group 3).
70                               Metastasectomy with curative intent has become standard practice for th
71 agnosed during surveillance who were treated with curative intent (hepatic resection, liver transplan
72  was generally less effective than treatment with curative intent; however, applicability to contempo
73 splantation is at present the only treatment with curative intent; however, the selection of patients
74 tant metastases warrant therapy administered with curative intent, ie, combined-modality therapy cons
75 postresectional CA 19-9 levels after surgery with curative intent in patients with pancreatic cancer.
76 erence in the percentage of patients treated with curative intent in the CEA group was 4.4% (95% CI,
77 the basis of these data, active surveillance with curative intent, in which active treatment is delay
78 odels indicated incidence rates of treatment with curative intent increased 17.6% per year during 200
79    A total of 39 patients (52%) were treated with curative intent (induction +/- HCT) and had a 2-y O
80 ead and neck squamous cell carcinoma treated with curative-intent intensity-modulated radiation thera
81 Improved survival after a complete resection with curative intent is often predicted by good performa
82 on among older adults and surgical resection with curative intent is the primary treatment of CRC.
83          However, multimodality therapy used with curative intent is toxic.
84 nts undergoing surgery for colorectal cancer with curative intent (January 2008-March 2012) were incl
85 ority of patients with rectal cancer treated with curative-intent neoadjuvant chemoradiotherapy do no
86 (P = .0019); for patients treated surgically with curative intent, only risk group predicted CFS (P =
87 ited stage cancer ( P = .035), those treated with curative intent ( P = .003), and those with a lower
88 ies have provided better therapeutic options with curative intent potential for some locoregional the
89 very 3 weeks, both administered concurrently with curative intent radiotherapy in patients with LAHNS
90  Synchronous surgical treatment of PC and LM with curative intent remains controversial.
91 hich 80% and 20% could be surgically treated with curative intent, respectively.
92 691 men with prostate adenocarcinoma treated with curative-intent RT between 1988 and 2006 were retro
93 outcome was surgical treatment of recurrence with curative intent; secondary outcomes were mortality
94  High-dose hematopoietic stem-cell therapies with curative intent should be considered as standard th
95                          Patients approached with curative intent should undergo aggressive attempts
96 Tissue microarrays from 145 patients treated with curative intent showed HGAL staining in 75% and was
97 ith stage I-II disease received radiotherapy with curative intent, showing a 3-year OS of 93%.
98 ), radiotherapy (RT), or both (CRT) compared with curative-intent surgery alone for resected BTC were
99 ncer care: during treatment, after treatment with curative intent (survivorship), and after diagnosis
100 osed between 1995 and 2008, were not treated with curative intent therapy, and received follow-up thr
101 mical recurrence after primary PCa treatment with curative intent, three or fewer extracranial metast
102  biochemical relapse after radical treatment with curative intent to a lethal castrate-resistant meta
103 he basis of radiographic images were treated with curative intent using a multimodality approach invo
104             Surgical treatment of recurrence with curative intent was 2.3% (7/301) in the minimum fol
105                                    Resection with curative intent was performed on 118 of 684 patient
106 creased risk of death, whereas prior surgery with curative intent was protective.
107 he head and neck who were treated surgically with curative intent were enrolled in our prospective mu
108 t surgery for exocrine pancreatic malignancy with curative intent were identified from a prospective
109 s measuring at least 5.0 cm and were treated with curative intent were identified.
110 ewly diagnosed from 2000 to 2012 and treated with curative intent were included from the United State
111 ould be amenable to additional local therapy with curative intent, whereas metastatic disease would r
112 rcinoma and who underwent surgical resection with curative intent while residing in one of the 11 Sur
113 carcinoma of the glottic larynx were treated with curative intent with radiotherapy alone (73 patient
114                          In patients treated with curative intent with VEPEMB, ABVD, and CLVPP (n = 1
115 % CI, 4.6%-7.2%) were treated for recurrence with curative intent, with little difference according t

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top